FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
0.3099
-0.0039 (-1.24%)
At close: Mar 31, 2025, 4:00 PM
0.3125
+0.0026 (0.83%)
After-hours: Mar 31, 2025, 7:56 PM EDT
FibroGen Market Cap
FibroGen has a market cap or net worth of $31.27 million as of March 31, 2025. Its market cap has decreased by -84.85% in one year.
Market Cap
31.27M
Enterprise Value
70.97M
1-Year Change
-84.85%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $31.27M, a decrease of -97.45%. That is a compound annual growth rate of -29.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 31.30M | -41.28% |
| Dec 31, 2024 | 53.30M | -38.81% |
| Dec 29, 2023 | 87.10M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |